It has been reported that COX2 expression in tumor epithelial cells was stimulated in response to inflammatory or stromal fibroblasts during the progression of ductal carcinoma in situ (DCIS) to invasive breast carcinomas in a tumor xenograft model [11]. The gene discussed is PTGER2; the disease is ductal breast carcinoma in situ.